Related Experiment Video
Updated: Jul 5, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Effects of intravenous and intracoronary adenosine 5'-triphosphate as compared with adenosine on coronary flow and
A Jeremias1, S D Filardo, R J Whitbourn
1Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Insights
Adenosine triphosphate (ATP) is equivalent to adenosine for assessing coronary stenosis via coronary flow reserve (CFR) and fractional flow reserve (FFR). However, neither drug induces maximal hyperemia compared to complete coronary occlusion.
Area of Science:
- Cardiovascular physiology
- Interventional cardiology
- Pharmacology
Background:
- Coronary flow reserve (CFR) and fractional flow reserve (FFR) measurements require maximal hyperemia.
- Adenosine is the standard hyperemia-inducing agent but has drawbacks like cost and tolerability.
Purpose of the Study:
- To evaluate adenosine triphosphate (ATP) as an alternative to adenosine for inducing hyperemia.
- To compare the efficacy of ATP and adenosine in CFR and FFR measurements.
Main Methods:
- Equivalency testing of ATP and adenosine in canines and human stenoses.
- Measurements of CFR and FFR using intracoronary ATP, adenosine, and coronary occlusion.
- Dosage-response assessment for both agents.
Main Results:
- Both ATP and adenosine significantly increased CFR and FFR, with higher doses yielding greater hyperemia.
- ATP and adenosine demonstrated excellent linear correlation for CFR (R=0.934) and FFR (R=0.985).
- Hyperemic response to ATP and adenosine was less than that achieved by coronary occlusion.
Conclusions:
- Increased dosages of ATP and adenosine enhance coronary hyperemia beyond standard clinical recommendations.
- ATP is therapeutically equivalent to adenosine for CFR and FFR assessment.
- Neither pharmacological agent achieved maximal hyperemia; coronary occlusion provided a superior hyperemic response.
Background:
Measurements of Doppler derived coronary flow reserve (CFR) and pressure derived fractional flow reserve (FFR) for coronary stenosis assessment depend on the induction of maximal hyperemia. Adenosine is the most widely used pharmacological agent but is expensive and poorly tolerated by some patients.
Methods And Results:
The objective of this study was to test the equivalency of adenosine 5'-triphosphate (ATP) to adenosine in their ability to cause maximal hyperemia as compared with the hyperemic response of complete coronary occlusion in 6 canines. Intracoronary administration of either ATP or adenosine resulted in a significant increase in CFR (2.79+/-0.64 and 2.22+/-0.7 for 10 microgram versus 4. 65+/-1.22 and 4.25+/-0.78 for 100 microgram for ATP and adenosine, respectively, P for trend <0.001) but not reaching the level of coronary occlusion (6.35+/-2.26). Additionally, FFR and CFR were measured in 35 different stenoses using ATP, adenosine, and coronary occlusion. There was an excellent linear correlation between ATP and adenosine for both CFR (R=0.934, P<0.001) and FFR (R=0.985, P<0.001). However, hyperemia with either ATP or adenosine was less than postocclusion hyperemia, resulting in significantly different reserve measurements (CFR: 1.93+/-0.66 and 2.08+/-0.81 versus 2.35+/-0.97, P<0.001; FFR: 0.62+/-0.24 and 0.63+/-0.23 versus 0.58+/-0.2, P<0.001).
Conclusions:
1) Step up in dosage of ATP and adenosine beyond currently recommended clinical doses resulted in a significant increase in coronary hyperemia; 2) ATP was equivalent to adenosine for both CFR and FFR; and 3) complete coronary occlusion yielded a better hyperemic response than either drug, indicating that maximal hyperemia was not achieved by either pharmacological stimulus.
Related Concept Videos
Pathophysiology of Cardiac Performance
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Imaging Studies for Cardiovascular System V: CT
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Cardiopulmonary Resuscitation IV: Pharmacological Management

